Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.86
Delayed Data
As of Jun 24
 -0.34 / -5.48%
Today’s Change
2.80
Today|||52-Week Range
10.51
+16.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash0.0025.8M74.3M200.3M
 
 
 
 
Short Term Investment Cash-20.6M41.0M18.6M126.8M
 
 
 
 
 
Cash & Short Term Investments14.7M55.7M85.8M200.3M
 
 
 
 
 
 
ReceivablesReceivables0.00--882.0K4.3M
 
 
 
 
InventoriesInventories----7.8M41.9M
 
 
 
 
Current AssetsOther Current Assets430.0K1.2M4.1M2.8M
 
 
 
 
 
Current Assets15.1M56.9M98.6M249.3M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross879.0K1.2M2.7M5.5M
 
 
 
 
 
Depreciation-823.0K-877.0K-1.2M-452.0K
 
 
 
 
 
Intangible Assets3.2M3.2M3.2M3.2M
 
 
 
 
 
Other Assets3.4M3.5M3.5M4.3M
 
 
 
 
 
Total Assets18.6M60.8M103.6M258.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable7.2M14.0M24.1M21.3M
 
 
 
 
 
Other Current Liabilities0.000.00414.0K50.8M
 
 
 
Other Liabilities8.0M15.3M29.3M77.6M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.000.0090.8M
 
 
Deferred Taxes0.000.00-700.0K-790.0K
 
 
 
Other Liabilities36.0K38.0K133.0K2.6M
 
 
 
 
 
Total Liabilities8.1M15.4M30.1M171.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity10.5M45.4M73.5M86.9M
 
 
 
 
 
Total Shareholder Equity10.5M45.4M73.5M86.9M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding71.9M82.6M92.7M105.1M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.